ロード中...

Gene mutation and surgical technique: suggestion or more?

Advancements in chemotherapy and molecular targeted therapy have improved long-term outcomes for patients with resectable colorectal liver metastases (CLM). RAS mutation status was an original focus as a molecular biomarker as it predicted treatments response to anti-epidermal growth factor receptor...

詳細記述

保存先:
書誌詳細
出版年:Surg Oncol
主要な著者: Kawaguchi, Yoshikuni, Lillemoe, Heather A., Vauthey, Jean-Nicolas
フォーマット: Artigo
言語:Inglês
出版事項: 2019
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6980434/
https://ncbi.nlm.nih.gov/pubmed/31351766
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.suronc.2019.07.004
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!